1-19 of 19
Authors: Chelsea Mayoh
Sort by
Journal Article
Germline analysis of an international cohort of pediatric diffuse midline glioma patients
Marion K Mateos and others
Neuro-Oncology, noaf061, https://doi.org/10.1093/neuonc/noaf061
Published: 12 March 2025
Journal Article
ACCEPTED MANUSCRIPT
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic
Dannielle H Upton and others
Neuro-Oncology, noaf035, https://doi.org/10.1093/neuonc/noaf035
Published: 12 February 2025
Journal Article
DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES
Marion K Mateos and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.129
Published: 18 June 2024
Journal Article
DIPG-35. OVERCOMING THE BLOOD-BRAIN BARRIER CHALLENGE IN DIFFUSE MIDLINE GLIOMA
Maria Tsoli and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.088
Published: 18 June 2024
Journal Article
DIPG-24. COMBINED EPIGENETIC THERAPY WITH FACT AND BET INHIBITORS REMODELS CHROMATIN AND DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA
Holly Holliday and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.077
Published: 18 June 2024
Journal Article
DIPG-48. PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
Campbell McKay and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.101
Published: 18 June 2024
Journal Article
DIPG-50. TARGETING VULNERABILITIES IN PAEDIATRIC DIFFUSE MIDLINE GLIOMAS: LEVERAGING PLK1 INHIBITION TO EXPLOIT RAS/PI3K PATHWAY DEPENDENCY
Elisha Hayden and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.103
Published: 18 June 2024
Journal Article
DDEL-07. BARRIER TO PROGRESS: DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) INDUCES A TIGHTENED BLOOD-BRAIN BARRIER PHENOTYPE
Caitlin Ung and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v102–v103, https://doi.org/10.1093/neuonc/noad179.0386
Published: 10 November 2023
Journal Article
DDDR-30. IDENTIFICATION OF DRIVERS OF RESISTANCE IN BRAFV600E PEDIATRIC HIGH-GRADE GLIOMA AND NOVEL THERAPEUTIC TARGETS
Rebecca Lehmann and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v112, https://doi.org/10.1093/neuonc/noad179.0423
Published: 10 November 2023
Journal Article
HGG-20. NOVEL PAEDIATRIC CASE OF A SPINAL HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES IN A PATIENT WITH NOONAN SYNDROME
Jordan Staunton and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i44, https://doi.org/10.1093/neuonc/noad073.169
Published: 12 June 2023
Journal Article
DIPG-21. DIPG cells alter the permeability of the blood-brain barrier in the brainstem leading to treatment failure.
Caitlin Ung and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i22, https://doi.org/10.1093/neuonc/noac079.078
Published: 03 June 2022
Journal Article
DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
Holly Holliday and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i18, https://doi.org/10.1093/neuonc/noac079.063
Published: 03 June 2022
Journal Article
HGG-09. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG
Anahid Ehteda and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i18–i19, https://doi.org/10.1093/neuonc/noab090.075
Published: 01 June 2021
Journal Article
RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
Aaminah Khan and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i40–i41, https://doi.org/10.1093/neuonc/noab090.163
Published: 01 June 2021
Journal Article
DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
Dong-Anh Khuong-Quang and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii302, https://doi.org/10.1093/neuonc/noaa222.117
Published: 04 December 2020
Journal Article
DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION
Anahid Ehteda and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii292, https://doi.org/10.1093/neuonc/noaa222.076
Published: 04 December 2020
Journal Article
DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
Aaminah Khan and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii289–iii290, https://doi.org/10.1093/neuonc/noaa222.065
Published: 04 December 2020
Journal Article
DIPG-50. A NOVEL ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL OF RADIATION-INDUCED GLIOMA
Jacqueline Whitehouse and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii296, https://doi.org/10.1093/neuonc/noaa222.095
Published: 04 December 2020
Journal Article
THER-23. RESULTS OF THE ZERO CHILDHOOD CANCER INTEGRATED PRECISION MEDICINE PLATFORM FOR PAEDIATRIC HIGH-RISK BRAIN TUMOURS
Maria Tsoli and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii118, https://doi.org/10.1093/neuonc/noz036.228
Published: 23 April 2019
Advertisement
Advertisement